Researchers at FutureNeuro SFI Research Centre for Chronic and Rare Neurological Diseases, RCSI University of Medicine and Health Sciences, NUI Galway and Queen’s University Belfast have today launched the All-Ireland MS Research Network.

The All-Ireland MS Research Network will be the largest collaboration of multiple sclerosis researchers across the island of Ireland, providing a unique opportunity for scientists, clinicians and people with mulitple sclerosis in Ireland to accelerate MS research, going from the patient to the bench and bringing discovery research forward to benefit the patient. The network holds potential to limit the progression of MS, to train future generations of MS researchers and to contribute to global MS research.

Multiple sclerosis is one of the most common causes of neurological disability in young people and is increasing in incidence and prevalence around the world. Currently, there are approximately 13,500 people on the island of Ireland living with MS (4,500 in Northern Ireland and 9,000 in the Republic of Ireland).

The goals of the All-Ireland MS Research Network are to:

  • Deliver cutting-edge research in multiple sclerosis that focuses on limiting disease progression
  • Train the next generations of leaders in multiple sclerosis research
  • Communicate multiple sclerosis research activities and discoveries to the public, research community and key stakeholders
  • Collaborate on multiple sclerosis research programmes nationally and internationally to achieve the mission of the network

 

The network’s founding investigators are FutureNeuro Funded Investigator and RCSI, Dr Claire McCoy, Dr Una FitzGerald and Dr Jill McMahon, NUI Galway; and Professor Denise Fitzgerald, Dr Alerie Guzman de la Fuente and Dr Yvonne Dombrowski, Queen’s University Belfast. Together, they have reached out to dozens of multi-disciplinary multiple sclerosis researchers across the island of Ireland, drawn from hospitals, MS day-care centres, universities, and from those who have multiple sclerosis.

Dr Claire McCoy, SFI FutureNeuro Funded Investigator and RCSI School of Pharmacy and Biomolecular Sciences, said: “The founding members have worked tirelessly over the last 12 months to define the All-Ireland MS Research Network’s goals, aspirations and research mission. We firmly believe that closer collaborations and sharing of ideas and expertise across the network will lead to exciting discoveries that better explain multiple sclerosis pathology and symptoms, and that could be the basis of new approaches to MS disease management. The network will facilitate excellence in new multiple sclerosis research discoveries that might otherwise not happen.”

Alexis Donnelly, has lived with progressive MS for nearly 30 years, and is excited by the formation of AIMS-RN: “This network will facilitate MS researchers throughout the island to cooperate across institutional and disciplinary boundaries, linking them not only with each other but with international colleagues and allowing fresh results and insights to flow back and forth.  This can only accelerate the pace of research into progressive MS both nationally and internationally.’

AIMS-RN Research Summer Scholarships

Coinciding with the launch, AIMS-RN is opening a call for budding multiple sclerosis researchers, at undergraduate or early postgraduate level, to apply for the first AIMS-RN Research Summer Scholarships. Following a generous donation from Eamonn Haughton and Declan Smith, of Chemical Systems Control (CSC), Ltd, the first scholarship will be awarded this year to a successful candidate who is considering an MS-focused research career.

“New therapies for MS will be built on state-of-the-art research.  Funded junior researchers will spend time in research groups based in at least two of the participating organisations. It is hoped that the seeds sewn by this research will help to bring MS treatments to the next level.” Eamonn Haughton, CSC.

AIMS-RN’s aims, mission and ethos has been endorsed by the following organisations: MS Ireland, the UK MS Society, European MS Platform, Irish Institute for Clinical Neuroscience, Neuroscience Ireland, the Neurology Alliance of Ireland, the Dementia Research Network of Ireland, SFI-funded Research Centres FutureNeuro and CÚRAM (the Centre for Research on Medical Devices), the Dublin Brain Bank, the Galway Neuroscience Centre and Parkinson’s Tissue Bank.

MS is a chronic, immune-mediated condition of the central nervous system (brain, spinal cord and optic nerve). In MS, myelin damage results in a range of symptoms including impairment of mobility and vision as well as cognitive difficulties and severe fatigue.

For further information and details of how to apply for the AIMS-RN Research Summer Scholarships  visit www.aims-rn.org